Erratum for Hong et al. “Usefulness of Intravascular Ultrasound Guidance in Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents for Chronic Total Occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry)” Am J Cardiol 2014;114:534–540




This paper has errors in Table 3 . The correct table can be found below; values in bold are corrections from the original article.



Table 3

Analysis of clinical outcomes at 1 month, 1 year and 2 year















































































































































































































Variable Total population Matched population
IVUS guidance
(N = 206) 		Angiography
guidance
(N = 328) 		p-value IVUS
guidance
(N = 201) 		Angiography
guidance
(N = 201) 		p-value
1-month outcomes
Stent thrombosis 0 4 (1.2%) 0.304 0 4 (2.0%) 0.046
Myocardial infarction 1 (0.5%) 4 (1.2%) 0.653 1 (0.5%) 4 (2.0%) 0.180
Target lesion revascularization 0 0 1.000 0 0 1.000
Target vessel revascularization 0 3 (0.9%) 0.288 0 3 (1.5%) 0.083
Cardiac death 1 (0.5%) 3 (0.9%) 1.000 1 (0.5%) 3 (1.5%) 0.317
All cause of death 2 (1.0%) 2 (0.6%) 1.000 2 (1.0%) 3 (1.5%) 0.655
Major adverse cardiovascular event 1 (0.5%) 4 (1.2%) 0.653 1 (0.5%) 4 (2.0%) 0.180
1-year outcomes
Stent thrombosis 0 5 (1.5%) 0.162 0 5 (2.5%) 0.025
Myocardial infarction 2 (1.0%) 9 (2.7%) 0.217 2 (1.0%) 6 (3.0%) 0.157
Target lesion revascularization 12 (5.8%) 18 (5.5%) 0.869 12 (6.0%) 8 (4.0%) 0.371
Target vessel revascularization 15 (7.3%) 27 (8.2%) 0.691 15 (7.5%) 18 (9.0%) 0.578
Cardiac death 2 (1.0%) 7 (2.1%) 0.493 2 (1.0%) 4 (2.0%) 0.414
All cause of death 3 (1.5%) 8 (2.4%) 0.436 3 (1.5%) 4 (2.0%) 0.705
Major adverse cardiovascular event 12 (5.8%) 24 (7.3%) 0.503 12 (6.0%) 15 (7.5%) 0.549
2-year outcomes
Stent thrombosis 0 7 (2.1%) 0.047 0 6 (3.0%) 0.015
Myocardial infarction 2 (1.0%) 12 (3.7%) 0.058 2 (1.0%) 8 (4.0%) 0.061
Target lesion revascularization 17 (8.3%) 25 (7.6%) 0.869 17 (8.5%) 17 (8.5%) 0.896
Target vessel revascularization 21 (10.2%) 34 (10.4%) 0.949 21 (10.4%) 24 (11.9%) 0.631
Cardiac death 2 (1.0%) 8 (2.4%) 0.223 2 (1.0%) 5 (2.5%) 0.257
All cause of death 4 (1.9%) 11 (3.4%) 0.336 4 (2.0%) 6 (3.0%) 0.527
Major adverse cardiovascular event 18 (8.7%) 31 (9.5%) 0.781 18 (9.0%) 22 (10.9%) 0.610

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Effect of Anemia on Frequency of Short- and Long-Term Clinical Events in Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)
  2. Comparison of Age (<75 Years Versus ≥75 Years) to Risk of Ventricular Tachyarrhythmias and Implantable Cardioverter Defibrillator Shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)
  3. Comparison by Magnetic Resonance Phase Contrast Imagingof Pulse-Wave Velocity in Patients With Single Ventricle Who Have Reconstructed Aortas Versus Those Without
  4. Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With Acute Myocardial Infarction

Stay updated, free articles. Join our Telegram channel
Tags:
Dec 1, 2016 | Posted by in CARDIOLOGY | Comments Off on Erratum for Hong et al. “Usefulness of Intravascular Ultrasound Guidance in Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents for Chronic Total Occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry)” Am J Cardiol 2014;114:534–540

Full access? Get Clinical Tree
Get Clinical Tree app for offline access